The global pharmaceutical industry experienced extraordinary profits due to the circumstances of the Covid-19 pandemic, but how are players coping now that the Covid effect has receded? We speak to Deepti Saraf, General Manager of Roche Malaysia on the current pharmaceutical landscape, as well as efforts to improve affordability and accessibility of life-saving drugs.

Can ASEAN’s Digital Needs Push EdgePoint Past Key Pressures?
23:32

Pharmaniaga Post-PN17 Betting Big on Biopharma
23:56

Khairy Jamaluddin: Back in the Running
34:25